应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03933 联邦制药
休市中 08-16 16:08:20
9.500
+0.930
+10.85%
最高
9.650
最低
8.880
成交量
1,186万
今开
8.880
昨收
8.570
日振幅
8.98%
总市值
172.62亿
流通市值
172.62亿
总股本
18.17亿
成交额
1.11亿
换手率
0.65%
流通股本
18.17亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
联邦制药(03933)股价显著上升10.385%,现价港币$9.46
阿斯达克财经 · 08-16 11:53
联邦制药(03933)股价显著上升10.385%,现价港币$9.46
联邦制药(03933.HK)盈喜后涨11% 料上半年净溢利按年增12.9%
阿斯达克财经 · 08-16 11:26
联邦制药(03933.HK)盈喜后涨11% 料上半年净溢利按年增12.9%
医保目录初审名单公布!港股创新药ETF(159567)涨超2%,锐度和弹性充分体现,联邦制药涨9.57%。
每日经济新闻 · 08-16 10:09
医保目录初审名单公布!港股创新药ETF(159567)涨超2%,锐度和弹性充分体现,联邦制药涨9.57%。
联邦制药(03933)上涨10.04%,报9.43元/股
金融界 · 08-16 09:58
联邦制药(03933)上涨10.04%,报9.43元/股
港股异动 | 联邦制药(03933)盈喜后涨超7% 预计上半年净溢利同比增近13%至14.5亿元
智通财经 · 08-16 09:50
港股异动 | 联邦制药(03933)盈喜后涨超7% 预计上半年净溢利同比增近13%至14.5亿元
联邦制药盘中异动 早盘股价大涨5.36%报9.030港元
自选股智能写手 · 08-16 09:30
联邦制药盘中异动 早盘股价大涨5.36%报9.030港元
《盈喜》联邦制药(03933.HK)毛利增长 料半年溢利增至14.5亿人民币
阿斯达克财经 · 08-16 03:45
《盈喜》联邦制药(03933.HK)毛利增长 料半年溢利增至14.5亿人民币
联邦制药(03933)发盈喜 预计中期净溢利约为14.5亿元
智通财经 · 08-15 22:24
联邦制药(03933)发盈喜 预计中期净溢利约为14.5亿元
联邦制药(03933.HK)8月29日举行董事会会议考虑及批准中期业绩
格隆汇资讯 · 08-15 12:38
联邦制药(03933.HK)8月29日举行董事会会议考虑及批准中期业绩
联邦制药(03933.HK)创新药UBT251注射液完成Ia期临床研究
阿斯达克财经 · 08-13
联邦制药(03933.HK)创新药UBT251注射液完成Ia期临床研究
联邦制药(03933):1类创新药UBT251注射液已完成在中国健康受试者的Ia期临床研究
智通财经 · 08-12
联邦制药(03933):1类创新药UBT251注射液已完成在中国健康受试者的Ia期临床研究
联邦制药盘中异动 股价大跌5.03%
自选股智能写手 · 08-05
联邦制药盘中异动 股价大跌5.03%
联邦制药07月31日主力资金流入346万元 连续3日加仓
自选股智能写手 · 07-31
联邦制药07月31日主力资金流入346万元 连续3日加仓
港股概念追踪 | 糖尿病防治行动实施方案发布 这些企业药物创新研发进展显著(附概念股)
智通财经 · 07-30
港股概念追踪 | 糖尿病防治行动实施方案发布 这些企业药物创新研发进展显著(附概念股)
南向资金7月26日净买入联邦制药92.40万股 连续7日增持
自选股智能写手 · 07-29
南向资金7月26日净买入联邦制药92.40万股 连续7日增持
联邦制药07月26日主力资金流出121万元 连续3日减仓
自选股智能写手 · 07-26
联邦制药07月26日主力资金流出121万元 连续3日减仓
联邦制药07月25日遭主力抛售200万元 环比增加185.71%
自选股智能写手 · 07-25
联邦制药07月25日遭主力抛售200万元 环比增加185.71%
联邦制药7月23日获南向资金加仓443.40万股
自选股智能写手 · 07-24
联邦制药7月23日获南向资金加仓443.40万股
南向资金7月22日净买入联邦制药102.20万股 连续3日增持
自选股智能写手 · 07-23
南向资金7月22日净买入联邦制药102.20万股 连续3日增持
港股异动 | 联邦制药(03933)再涨超5% 胰岛素集采下企业业绩分化 机构看好公司核心产品保持快速增长
智通财经 · 07-22
港股异动 | 联邦制药(03933)再涨超5% 胰岛素集采下企业业绩分化 机构看好公司核心产品保持快速增长
公司概况
公司名称:
联邦制药
所属市场:
SEHK
上市日期:
--
主营业务:
联邦制药国际控股有限公司是一家投资控股公司,主要从事销售中间体产品、原料药及制剂产品业务。该公司通过三个业务部门运营业务。中间体部从事销售中间体产品业务。原料药部从事销售原料药业务。制剂产品部从事销售抗生素制剂产品、非抗生素制剂产品及空心胶囊业务。该公司通过其子公司还从事制造及销售有机化肥业务。
发行价格:
--
{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"联邦制药","latestPrice":9.5,"timestamp":1723795700032,"preClose":8.57,"halted":0,"volume":11862788,"delay":0,"floatShares":1817026508,"shares":1817026508,"eps":1.6179374,"marketStatus":"休市中","marketStatusCode":7,"change":0.93,"latestTime":"08-16 16:08:20","open":8.88,"high":9.65,"low":8.88,"amount":111151405,"amplitude":0.089848,"askPrice":9.51,"askSize":4000,"bidPrice":9.5,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":1.6179374502770827,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":8.57,"dividendRate":0.045823,"openAndCloseTimeList":[[1723771800000,1723780800000],[1723784400000,1723795200000]],"volumeRatio":6.869004930240618,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933/wiki","defaultTab":"wiki","newsList":[{"id":"2459563022","title":"联邦制药(03933)股价显著上升10.385%,现价港币$9.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2459563022","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459563022?lang=zh_cn&edition=full","pubTime":"2024-08-16 11:53","pubTimestamp":1723780380,"startTime":"0","endTime":"0","summary":"[上升股]联邦制药(03933) 股价在上午11:53比前收市价显著上升10.385%,现股价为港币$9.46。至目前为止,今日最高价为$9.46,而最低价为$9.46。总成交量为4000股,总成交金额为港币$3.784万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2408163130/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2459253989","title":"联邦制药(03933.HK)盈喜后涨11% 料上半年净溢利按年增12.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459253989","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459253989?lang=zh_cn&edition=full","pubTime":"2024-08-16 11:26","pubTimestamp":1723778760,"startTime":"0","endTime":"0","summary":"联邦制药(03933.HK) 连跌三个交易日后,股价今日(16日)高开3.6%报8.88元,现报9.53元,升11.2%,创近三个月高位,成交818万股,涉资7,595.97万元。公司发盈喜,预计上半年净溢利14.5亿元人民币,相较上年同期录得12.84亿元人民币,按年增长约12.9%,主要受惠中间体产品收入增加及生产成本持续降低,带动毛利增长约1.3亿元人民币;销售及分销开支减少2.6亿元人民币,抵销研发成本支出增加1亿元人民币。(jl/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-15 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180321105506969_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180321105506969_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1372232/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2459340662","title":"医保目录初审名单公布!港股创新药ETF(159567)涨超2%,锐度和弹性充分体现,联邦制药涨9.57%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2459340662","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459340662?lang=zh_cn&edition=full","pubTime":"2024-08-16 10:09","pubTimestamp":1723774189,"startTime":"0","endTime":"0","summary":"8月16日,A股港股携手反弹,港股创新药板块涨势居前。港股创新药ETF市场热度较高,过去10个交易日日均成交额1.09亿元,实时换手率突破19%。港股创新药ETF跟踪国证港股通创新药指数,前十大成份股占比超70%,聚焦创新药板块龙头,锐度和弹性较高,在美联储降息周期下迎来港股外资回流+创新药投融资向好的双重提振。中泰证券表示,医保局发布目录初审药品名单,关注弹性品种。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816101019959d0af9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816101019959d0af9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2459234545","title":"联邦制药(03933)上涨10.04%,报9.43元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459234545","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459234545?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:58","pubTimestamp":1723773529,"startTime":"0","endTime":"0","summary":"8月16日,联邦制药(03933)盘中上涨10.04%,截至09:58,报9.43元/股,成交3683.88万元。联邦制药国际控股有限公司主要从事药品的研发、生产和销售,拥有制剂、原料、生物、动保四大业务板块,九家生产研发实体的综合性制药集团,全球销售网络覆盖,员工人数达到15000余人。在荣膺多项行业荣誉基础上,公司在2022年的中国化药企业和医药工业百强排行榜分别位居第16和27名。截至2023年年报,联邦制药营业总收入137.4亿元、净利润27.01亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/16095842415751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2459231975","title":"港股异动 | 联邦制药(03933)盈喜后涨超7% 预计上半年净溢利同比增近13%至14.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459231975","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459231975?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:50","pubTimestamp":1723773040,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,联邦制药(03933)涨超7%,截至发稿,涨7.12%,报9.18港元,成交额2841万港元。消息面上,联邦制药发盈喜,预期截至2024年6月30日止六个月的净溢利约为人民币14.5亿元,而去年同期净溢利约为人民币12.84亿元,同比增长近13%。主要受惠于中间体产品收入增加及生产成本持续降低,带动毛利增长约人民币1.3亿元;销售及分销开支减少约2.6亿元,抵消研发成本支出增加约人民币1亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2459831231","title":"联邦制药盘中异动 早盘股价大涨5.36%报9.030港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459831231","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459831231?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:30","pubTimestamp":1723771832,"startTime":"0","endTime":"0","summary":"2024年08月16日早盘09时30分,联邦制药股票出现波动,股价大幅上涨5.36%。截至发稿,该股报9.030港元/股,成交量34.8万股,换手率0.02%,振幅1.75%。联邦制药股票所在的药品行业中,整体涨幅为0.01%。该信息摘要如下:联邦制药发布公告,预期集团截至2024年6月30日止六个月的净溢利约为人民币14.5亿元,而截至2023年6月30日止六个月净溢利约为人民币12.84亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093036a1d488d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093036a1d488d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2459404046","title":"《盈喜》联邦制药(03933.HK)毛利增长 料半年溢利增至14.5亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2459404046","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459404046?lang=zh_cn&edition=full","pubTime":"2024-08-16 03:45","pubTimestamp":1723751100,"startTime":"0","endTime":"0","summary":"联邦制药发盈喜,预计6月止六个月净溢利14.5亿人民币,相较上年同期录得12.84亿人民币。净溢利上升主要受惠中间体产品收入增加及生产成本持续降低,带动毛利增长约1.3亿人民币;及销售及分销开支减少2.6亿人民币,抵销研发成本支出的增加。)过往派息公布日期派息事项派息内容2024/03/27末期业绩普通股息:人民币 0.28 2024/03/27末期业绩特别股息:人民币 0.12 2023/08/29中期业绩普通股息:人民币 0.12﹙相当于港元 0.130739﹚2023/03/22末期业绩普通股息:人民币 0.1400﹙相当于港元 0.15322﹚AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210705160258091_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210705160258091_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1372093/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2459590475","title":"联邦制药(03933)发盈喜 预计中期净溢利约为14.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459590475","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459590475?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:24","pubTimestamp":1723731857,"startTime":"0","endTime":"0","summary":"智通财经APP讯,联邦制药(03933)发布公告,预期集团截至2024年6月30日止六个月的净溢利约为人民币14.5亿元,而截至2023年6月30日止六个月净溢利约为人民币12.84亿元。净溢利上升主要受惠于:(1)中间体产品收入增加及生产成本持续降低,带动毛利增长约人民币1.3亿元;及(2)销售及分销开支减少约2.6亿元,抵消研发成本支出增加约人民币1亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2459495950","title":"联邦制药(03933.HK)8月29日举行董事会会议考虑及批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2459495950","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459495950?lang=zh_cn&edition=full","pubTime":"2024-08-15 12:38","pubTimestamp":1723696700,"startTime":"0","endTime":"0","summary":"格隆汇8月15日丨联邦制药(03933.HK)公布,董事会将于2024年8月29日(星期四)举行会议,其中包括考虑及批准公司及其附属公司截至2024年6月30日止六个月的中期业绩,及宣派中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151238259f2c7ccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151238259f2c7ccc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2459493600","title":"联邦制药(03933.HK)创新药UBT251注射液完成Ia期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2459493600","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459493600?lang=zh_cn&edition=full","pubTime":"2024-08-13 00:52","pubTimestamp":1723481520,"startTime":"0","endTime":"0","summary":"联邦制药(03933.HK) 公布,公司自主研发的1类创新药UBT251注射液已完成在内地健康受试者的Ia期临床研究。结果显示,单次给药后各剂量组安全性和耐受性良好,无一例受试者退出,未发生严重不良事件,常见副反应为轻到中度的食欲减退和胃肠道相关不良事件。公司将快速推进 UBT251 注射液后续临床研究。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-12 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210705160257776_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210705160257776_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1370942/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","159992","BK1191","06978","03933","BK1161"],"gpt_icon":0},{"id":"2458986853","title":"联邦制药(03933):1类创新药UBT251注射液已完成在中国健康受试者的Ia期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2458986853","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458986853?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:43","pubTimestamp":1723470182,"startTime":"0","endTime":"0","summary":"智通财经APP讯,联邦制药 发布公告,公司全资附属公司联邦生物科技有限公司自主研发的 1 类创新药 UBT251 注射液已完成在中国健康受试者的 Ia 期临床研究。本研究采用随机、双盲、安慰剂对照,剂量递增的试验设计,旨在评估在健康受试者中单次皮下注射 UBT251 的安全性、耐受性、药代动力学和药效动力学。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06978","159992","03933","BK1191","BK1161"],"gpt_icon":0},{"id":"2457713767","title":"联邦制药盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457713767","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457713767?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:45","pubTimestamp":1722836720,"startTime":"0","endTime":"0","summary":"2024年08月05日下午盘13时45分,联邦制药股票出现异动,股价急速下挫5.03%。截至发稿,该股报8.311港元/股,成交量224.2万股,换手率0.12%,振幅5.94%。联邦制药股票所在的药品行业中,整体涨幅为0.08%。其相关个股中,泰凌医药(旧)、泰凌医药(新)、李氏大药厂涨幅较大,振幅较大的相关个股有泰凌医药(旧)、君圣泰医药-B、三爱健康集团,振幅分别为51.02%、19.46%、13.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805134520af95df7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805134520af95df7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2455090803","title":"联邦制药07月31日主力资金流入346万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2455090803","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455090803?lang=zh_cn&edition=full","pubTime":"2024-07-31 16:16","pubTimestamp":1722413803,"startTime":"0","endTime":"0","summary":"07月31日, 联邦制药股价涨3.57%,报收9.00元,成交金额3585万元,换手率0.22%,振幅4.72%,量比1.03。联邦制药今日主力资金净流入346万元,连续3日净流入,上一交易日主力净流入140万元,今日环比增加147.14%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为33.33%,平均涨幅为3.47%。该股近5个交易日上涨3.67%,主力资金累计净流入402万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出27万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407311617089570b856&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407311617089570b856&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2455646950","title":"港股概念追踪 | 糖尿病防治行动实施方案发布 这些企业药物创新研发进展显著(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2455646950","media":"智通财经","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455646950?lang=zh_cn&edition=full","pubTime":"2024-07-30 07:48","pubTimestamp":1722296934,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,7月29日,国家卫生健康委等14个部门联合制定并发布了《健康中国行动——糖尿病防治行动实施方案》。糖尿病是严重威胁我国居民健康的四大类慢性病之一。国内糖尿病诊断率和治疗率的持续提升,也进一步推动国内糖尿病防治市场不断扩容。近年来,众多上市公司加快糖尿病药物创新研发上的比拼和竞技。信达生物计划于近期向CDE递交玛仕度肽治疗2型糖尿病的新药上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","00460","BK1191","BK1600","HSCEI","01558","BK1515","HSTECH","03933","YANG"],"gpt_icon":1},{"id":"2455413570","title":"南向资金7月26日净买入联邦制药92.40万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2455413570","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455413570?lang=zh_cn&edition=full","pubTime":"2024-07-29 09:31","pubTimestamp":1722216702,"startTime":"0","endTime":"0","summary":"7月26日, 南向资金增持联邦制药92.40万股,连续7日增持。截止当日收盘,港股通共持有联邦制药20995.97万股,占流通股11.55%。港股通增持金额前五个股分别为工商银行、中国石油化工股份、农夫山泉、中国神华、中国平安。联邦制药近5个交易日上涨9.14%,港股通累计增持791.00万股;近20个交易日上涨7.02%,港股通累计增持1117.12万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407290946049ef418fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407290946049ef418fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2454392141","title":"联邦制药07月26日主力资金流出121万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2454392141","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454392141?lang=zh_cn&edition=full","pubTime":"2024-07-26 16:15","pubTimestamp":1721981720,"startTime":"0","endTime":"0","summary":"07月26日, 联邦制药股价涨2.55%,报收8.84元,成交金额4045万元,换手率0.25%,振幅2.78%,量比0.93。联邦制药今日主力资金净流出121万元,连续3日净流出,上一交易日主力净流出200万元,今日环比减少39.50%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为55.56%,平均跌幅为1.89%。该股近5个交易日上涨9.63%,主力资金累计净流出42万元;近20日主力资金累计净流出792万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407261615439eeca607&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407261615439eeca607&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2454845973","title":"联邦制药07月25日遭主力抛售200万元 环比增加185.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454845973","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454845973?lang=zh_cn&edition=full","pubTime":"2024-07-25 16:15","pubTimestamp":1721895329,"startTime":"0","endTime":"0","summary":"07月25日, 联邦制药股价跌1.15%,报收8.62元,成交金额4135万元,换手率0.26%,振幅3.33%,量比1.04。联邦制药今日主力资金净流出200万元,上一交易日主力净流出70万元,今日环比增加185.71%。该股近5个交易日上涨2.73%,主力资金累计净流入0万元;近20日主力资金累计净流出578万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725161551955959ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725161551955959ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2453014288","title":"联邦制药7月23日获南向资金加仓443.40万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453014288","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453014288?lang=zh_cn&edition=full","pubTime":"2024-07-24 09:31","pubTimestamp":1721784700,"startTime":"0","endTime":"0","summary":"7月23日, 南向资金增持联邦制药443.40万股,连续4日增持。截止当日收盘,港股通共持有联邦制药20750.57万股,占流通股11.41%。联邦制药近5个交易日上涨3.94%,港股通累计增持633.80万股;近20个交易日下跌0.47%,港股通累计增持718.52万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072409453595549de5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072409453595549de5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2453722234","title":"南向资金7月22日净买入联邦制药102.20万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2453722234","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453722234?lang=zh_cn&edition=full","pubTime":"2024-07-23 09:31","pubTimestamp":1721698297,"startTime":"0","endTime":"0","summary":"7月22日, 南向资金增持联邦制药102.20万股,连续3日增持。截止当日收盘,港股通共持有联邦制药20307.17万股,占流通股11.17%。联邦制药近5个交易日上涨3.41%,港股通累计增持247.40万股;近20个交易日下跌2.75%,港股通累计增持264.52万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072309442495515519&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072309442495515519&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2453782049","title":"港股异动 | 联邦制药(03933)再涨超5% 胰岛素集采下企业业绩分化 机构看好公司核心产品保持快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2453782049","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453782049?lang=zh_cn&edition=full","pubTime":"2024-07-22 11:55","pubTimestamp":1721620537,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,联邦制药再涨超5%,截至发稿,涨5.43%,报8.54港元,成交额1612.92万港元。国元国际此前指出,联邦制药2023年全年收入137.39亿元人民币,同比增长21.2%,归母净利润为27亿元人民币,同比增长70.9%,每股股息0.52元,同比增长108%。核心产品将会继续保持快速增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","BK1191","03933","YANG","HSCEI"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":0.1098},{"period":"1month","weight":0.16},{"period":"3month","weight":-0.0076},{"period":"6month","weight":0.295},{"period":"1year","weight":0.4105},{"period":"ytd","weight":0.4299}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":-0.0174},{"period":"3month","weight":-0.1086},{"period":"6month","weight":0.0667},{"period":"1year","weight":-0.0489},{"period":"ytd","weight":0.0225}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"联邦制药国际控股有限公司是一家投资控股公司,主要从事销售中间体产品、原料药及制剂产品业务。该公司通过三个业务部门运营业务。中间体部从事销售中间体产品业务。原料药部从事销售原料药业务。制剂产品部从事销售抗生素制剂产品、非抗生素制剂产品及空心胶囊业务。该公司通过其子公司还从事制造及销售有机化肥业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":-0.034665},{"month":2,"riseRate":0.705882,"avgChangeRate":0.071347},{"month":3,"riseRate":0.647059,"avgChangeRate":0.036174},{"month":4,"riseRate":0.647059,"avgChangeRate":0.088789},{"month":5,"riseRate":0.647059,"avgChangeRate":0.040038},{"month":6,"riseRate":0.235294,"avgChangeRate":-0.014729},{"month":7,"riseRate":0.5,"avgChangeRate":0.011846},{"month":8,"riseRate":0.5,"avgChangeRate":0.028318},{"month":9,"riseRate":0.411765,"avgChangeRate":-0.016312},{"month":10,"riseRate":0.647059,"avgChangeRate":0.005911},{"month":11,"riseRate":0.411765,"avgChangeRate":-0.027018},{"month":12,"riseRate":0.411765,"avgChangeRate":0.008035}],"exchange":"SEHK","name":"联邦制药","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联邦制药,03933,联邦制药股票,联邦制药股票老虎,联邦制药股票老虎国际,联邦制药行情,联邦制药股票行情,联邦制药股价,联邦制药股市,联邦制药股票价格,联邦制药股票交易,联邦制药股票购买,联邦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}